FLOSEQUINAN

被引:14
作者
BARNETT, DB
机构
[1] Department of Pharmacology and Therapeutics, Leicester Royal Infirmary, Leicester, LE2 7LX, Clinical Sciences Building
关键词
D O I
10.1016/0140-6736(93)90498-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:733 / 736
页数:4
相关论文
共 25 条
[11]  
HAAS GJ, 1990, CLIN CARDIOL, V13, P414
[12]   LACK OF EFFECT OF FLOSEQUINAN ON THE PHARMACOKINETICS OF THEOPHYLLINE [J].
KAMALI, F ;
EDWARDS, C ;
RAWLINS, MD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (01) :124-126
[13]  
KANEL WB, 1989, CARDIOL CLIN, V7, P1
[14]  
KESSLER P, 1986, CIRCULATION, V74, P509
[15]   HEMODYNAMIC-EFFECTS OF BTS-49465, A NEW LONG-ACTING SYSTEMIC VASODILATOR DRUG, IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE [J].
KESSLER, PD ;
PACKER, M .
AMERICAN HEART JOURNAL, 1987, 113 (01) :137-143
[16]  
KROMER EP, 1990, J CARDIOL S1, V79, P150
[17]   THE EFFECTS OF FLOSEQUINAN ON ENDOTHELIN-1-INDUCED CHANGES IN INOSITOL 1,4,5-TRISPHOSPHATE LEVELS AND PROTEIN-KINASE-C ACTIVITY IN RAT AORTA [J].
LANG, D ;
LEWIS, MJ .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 226 (03) :259-264
[18]  
PACKER M, 1980, CIRCULATION, V82, P1280
[19]  
PITT B, 1991, CIRCULATION, V84, P1238
[20]  
REIGGER GAJ, 1990, CARDIOVASC DRUG THER, V4, P1395